Cardiac hypoxia imaging: Second-generation analogues of 64Cu-ATSM

Journal of Nuclear Medicine

Volumn 55, Issue 3, 2014, Pages 488-494

  Handley, Maxwell G ^a   Medina, Rodolfo A ^a   Mariotti, Erika ^a   Kenny, Gavin D ^a   Shaw, Karen P ^a   Yan, Ran ^a   Eykyn, Thomas R ^a   Blower, Philip J ^a   Southworth, Richard ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Bis(thiosemicarbazones); Cardiac ischemia; Hypoxia; PET

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2,3 BUTANEDIONE BIS(THIOSEMICARBAZONE) CU 64; 2,3 PENTANEDIONE BIS(THIOSEMICARBAZONE) CU 64; BUFFER; DIACETYL BIS (N4 METHYLTHIOSEMICARBAZONE) CU 64; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; COPPER (II) DIACETYL DI(N(4) METHYLTHIOSEMICARBAZONE); COPPER (II) DIACETYL-DI(N(4)-METHYLTHIOSEMICARBAZONE); DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; THIOSEMICARBAZONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CARDIAC IMAGING; CARDIOSELECTIVITY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RETENTION; DRUG UPTAKE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; IN VIVO STUDY; LIPOPHILICITY; LIVER; LUNG; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; 18FMISO; 64CU-ATSM; ANIMAL; BIS(THIOSEMICARBAZONES); CELL HYPOXIA; CHEMISTRY; CYTOLOGY; HEART MUSCLE; HYPOXIA; PET; WISTAR RAT;

18FMISO; 64CU-ATSM; BIS(THIOSEMICARBAZONES); CARDIAC ISCHEMIA; HYPOXIA; PET;

ANIMALS; CELL HYPOXIA; MALE; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR; THIOSEMICARBAZONES;

EID: 84899475858     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.129015     Document Type: Article

References (26)

1. Sabbah HN, Sharov VG, Goldstein S. Cell death, tissue hypoxia and the progression of heart failure. Heart Fail Rev. 2000;5:131-138.
2. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317-2325.
3. Handley MG, Medina RA, Nagel E, Blower PJ, Southworth R. PET imaging of cardiac hypoxia: opportunities and challenges. J Mol Cell Cardiol. 2011;51: 640-650.
4. Sinusas AJ. The potential of myocardial imaging with hypoxia markers. Semin Nucl Med. 1999;29:330-338.
5. Dearling JLJ, Lewis JS, Mullen GED, Rae MT, Zweit J, Blower PJ. Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur J Nucl Med. 1998;25:788-792.
6. Dearling JL, Lewis J, Mullen G, Welch M, Blower P. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. J Biol Inorg Chem. 2002;7:249-259.
7. Dearling JLJ, Lewis JS, McCarthy DW, Welch MJ, Blower PJ. Redox-active metal complexes for imaging hypoxic tissues: structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes. Chem Comms. 1998;22:2531-2532.
8. Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med. 1999;40:177-183.
9. Handley MG, Medina RA, Paul RL, Blower PJ, Southworth R. Demonstration of the retention of 64Cu-ATSM in cardiac myocytes using a novel incubation chamber for screening hypoxia-dependent radiotracers. Nucl Med Commun. 2013;34:1015-1022.
10. Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper- 62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential J Nucl Med. 1997;38:1155-1160.
11. Dence CS, Ponde DE, Welch MJ, Lewis JS. Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer. Nucl Med Biol. 2008;35: 713-720.
12. Lewis JS, Herrero P, Sharp TL, et al. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). J Nucl Med. 2002;43:1557-1569.
13. Kositwattanarerk A, Oh M, Kudo T, et al. Different distribution of 62Cu ATSM and 18F-FDG in head and neck cancers. Clin Nucl Med. 2012;37:252-257.
14. Lewis JS, Laforest R, Dehdashti F, Grigsby PW, Welch MJ, Siegel BA. An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix. J Nucl Med. 2008;49:1177-1182.
15. Takahashi N, Fujibayashi Y, Yonekura Y, et al. Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia. Ann Nucl Med. 2001;15:293-296.
16. McQuade P, Martin KE, Castle TC, et al. Investigation into 64Cu-labeled bis (selenosemicarbazone) and bis(thiosemicarbazone) complexes as hypoxia imaging agents. Nucl Med Biol. 2005;32:147-156.
17. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol. 1996;23:957-980.
18. Oh SJ, Chi DY, Mosdzianowski C, et al. Fully automated synthesis of [18F] fluoromisonidazole using a conventional [18F]FDG module. Nucl Med Biol. 2005;32:899-905.
19. John EK, Green MA. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato) copper(II) derivatives. J Med Chem. 1990;33:1764-1770.
20. Southworth R, Garlick PB. Dobutamine responsiveness, PET mismatch, and lack of necrosis in low-flow ischemia: is this hibernation in the isolated rat heart? Am J Physiol Heart Circ Physiol. 2003;285:H316-H324.
21. Urdal P, Stromme JH. Effects of Ca, Mg, and EDTA on creatine kinase activity in cerebrospinal fluid. Clin Chem. 1979;25:147-150.
22. Ng CK, Sinusas AJ, Zaret BL, Soufer R. Kinetic analysis of technetium-99mlabeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia. Circulation. 1995;92:1261-1268.
23. Okada RD, Johnson G III, Nguyen KN, Edwards B, Archer CM, Kelly JD. 99mTc-HL91: effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation. 1997;95:1892-1899.
24. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. J Nucl Med. 1989;30:1843-1847.
25. Dearling JLJ, Packard AB. Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM. Nucl Med Biol. 2010;37:237-243.
26. Wood KA, Honess DJ, Maxwell RJ, et al. Evaluation of the effects of blood flow on 64Cu-ATSM uptake in a rodent tumour model [abstract]. Clin Oncol. 2007; 19(suppl):S50.